By Bhanvi Satija LONDON, Sept 7 (Reuters) - Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed ...

Novo Nordisk A/S stopped two more trials for its experimental heart disease medicine, in a further blow to the drug’s ...

Earlier this year, Novo said ziltivekimab failed to reduce the risk of heart attacks and strokes, diminishing expectations ...

India's heart valve disease burden and TAVI adoption are growing, but access, awareness, and reimbursement issues need to be ...

AIIMS probes a 15-year-old’s death after years of congenital heart disease care, highlighting the challenges of treating ...

The World Health Organisation (WHO) says excessive environmental noise is associated with sleep disturbance, hearing ...

Doctors have spent years warning about high blood pressure, poor diet and smoking as drivers of heart disease, but a growing ...

A Chinese medical team achieved a world first by successfully using an AI-driven, ultrasound-guided ...

From aortic stenosis to the five variants of a common liver disease, Mayo Clinic scientists recently published research papers in three major journals.

New heart attack definition promises better care for women The conference kicked off with the announcement that the world’s ...

Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the ...

Those prescribed paracetamol saw a significant increase in their blood pressure compared with those taking the placebo. All ...